Fidelity Investments’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Buy |
9,053,034
+14,481
| +0.2% | +$217K | 0.01% | 981 |
|
|
2025
Q1 | $146M | Buy |
9,038,553
+237,287
| +3% | +$3.83M | 0.01% | 933 |
|
|
2024
Q4 | $205M | Buy |
8,801,266
+1,177,385
| +15% | +$27.4M | 0.01% | 816 |
|
|
2024
Q3 | $224M | Buy |
7,623,881
+115,898
| +2% | +$3.41M | 0.01% | 792 |
|
|
2024
Q2 | $177M | Buy |
7,507,983
+924,228
| +14% | +$21.7M | 0.01% | 829 |
|
|
2024
Q1 | $247M | Buy |
6,583,755
+2,797,878
| +74% | +$105M | 0.02% | 716 |
|
|
2023
Q4 | $79.7M | Buy |
+3,785,877
| New | +$79.7M | 0.01% | 1098 |
|
|
2022
Q3 | – | Sell |
-60
| Closed | -$1K | – | 5385 |
|
|
2022
Q2 | $1K | Buy |
60
+55
| +1,100% | +$917 | ﹤0.01% | 4801 |
|
|
2022
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 5467 |
|